UNSPSC 51273802: Alcohol/arnica

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE650. This VA Drug Class (DE650) classifies this compound as belonging to the group ANALGESICS, TOPICAL.

UNSPSC 51273802 Alcohol/arnica is a Commodity code that captures state and local procurement of pharmaceutical and over-the-counter products, including naloxone, generic pharmaceuticals, and OTC items distributed through health agencies, cooperative purchasing alliances, and community health systems. The recent opportunities show that state and local governments are buying naloxone and drug deactivation systems for public health initiatives, generic multi-source pharmaceuticals for distribution across state and local facilities, and exploring direct-to-manufacturer prescription programs to improve cost management and fulfillment efficiency. Issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, serving Minnesota, Oregon, and other participating jurisdictions). Vendors must comply with FDA requirements, current Good Manufacturing Practices (cGMP), the Drug Supply Chain Security Act (DSCSA), workers' compensation and commercial general liability insurance, and federal regulations when FEMA or other federal funding is present.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, response due July 26, 2023. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather market intelligence on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and wholesaler arrangements. MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products, requiring vendors to supply through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health, and Morris & Dickson Co., LLC) with proposals due March 26, 2026, and contract awards effective July 1, 2026. Vendors must maintain contractual relationships with at least two of the three authorized wholesalers and demonstrate pricing flexibility through fixed-price, net-price, or WAC-minus structures; evaluation weights price competitiveness at 75 percent.